The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2
Francesco Ferrara, G. Granata, Chiara Pelliccia, Raffaele La Porta, Antonio Vitiello
Topics & Concepts
PirfenidoneInflammationCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Value (mathematics)2019-20 coronavirus outbreakPharmacologyImmunologyVirologyInternal medicineDiseaseLungOutbreakInfectious disease (medical specialty)Idiopathic pulmonary fibrosisComputer scienceMachine learningInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLong-Term Effects of COVID-19COVID-19 Clinical Research Studies